Crossmark Global Holdings’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$543K Sell
10,551
-623
-6% -$32.1K 0.01% 852
2025
Q1
$655K Buy
11,174
+9
+0.1% +$528 0.01% 755
2024
Q4
$804K Hold
11,165
0.01% 647
2024
Q3
$893K Sell
11,165
-90
-0.8% -$7.2K 0.02% 649
2024
Q2
$807K Sell
11,255
-666
-6% -$47.8K 0.02% 655
2024
Q1
$839K Buy
11,921
+107
+0.9% +$7.53K 0.02% 672
2023
Q4
$911K Sell
11,814
-833
-7% -$64.2K 0.02% 625
2023
Q3
$878K Sell
12,647
-489
-4% -$33.9K 0.02% 606
2023
Q2
$1.1M Sell
13,136
-1,508
-10% -$126K 0.02% 565
2023
Q1
$1.09M Buy
14,644
+3,428
+31% +$254K 0.03% 557
2022
Q4
$930K Buy
11,216
+2,876
+34% +$238K 0.02% 594
2022
Q3
$592K Buy
8,340
+108
+1% +$7.67K 0.02% 704
2022
Q2
$714K Buy
8,232
+800
+11% +$69.4K 0.02% 673
2022
Q1
$804K Sell
7,432
-240
-3% -$26K 0.02% 706
2021
Q4
$992K Sell
7,672
-10,920
-59% -$1.41M 0.02% 629
2021
Q3
$2.25M Buy
18,592
+2,820
+18% +$342K 0.05% 355
2021
Q2
$1.78M Sell
15,772
-1,320
-8% -$149K 0.04% 425
2021
Q1
$1.63M Sell
17,092
-280
-2% -$26.7K 0.04% 439
2020
Q4
$1.38M Buy
17,372
+280
+2% +$22.2K 0.03% 475
2020
Q3
$1.06M Buy
17,092
+560
+3% +$34.7K 0.03% 518
2020
Q2
$1.09M Buy
16,532
+960
+6% +$63.4K 0.03% 508
2020
Q1
$738K Buy
15,572
+320
+2% +$15.2K 0.03% 549
2019
Q4
$837K Buy
15,252
+1,732
+13% +$95K 0.02% 610
2019
Q3
$661K Sell
13,520
-644
-5% -$31.5K 0.02% 675
2019
Q2
$738K Sell
14,164
-376
-3% -$19.6K 0.02% 644
2019
Q1
$722K Buy
14,540
+848
+6% +$42.1K 0.02% 648
2018
Q4
$495K Sell
13,692
-9,200
-40% -$333K 0.02% 773
2018
Q3
$1.17M Sell
22,892
-5,388
-19% -$275K 0.03% 547
2018
Q2
$1.05M Buy
28,280
+560
+2% +$20.7K 0.03% 583
2018
Q1
$1.05M Sell
27,720
-6,000
-18% -$227K 0.03% 596
2017
Q4
$1.09M Buy
33,720
+40
+0.1% +$1.3K 0.03% 614
2017
Q3
$1.02M Buy
+33,680
New +$1.02M 0.03% 604
2016
Q3
$1.02M Buy
+33,680
New +$1.02M 0.03% 604